Allegan, MI (February 22, 2023) – Padagis announced today the promotion of Pam Hoffman to the role of President. In this capacity, Pam will assume responsibility for Padagis’ global activities and will report directly to the Board.
In connection with this change, after almost 29 years of service to Padagis and its predecessor companies, Sharon Kochan will be retiring as CEO and will transition out of the company over the next two quarters. During this transition period, Sharon will advise and consult with the Padagis Board and leadership team to ensure a seamless transition. The Board and Sharon are proud of what they have accomplished together and the Board thanks Sharon for his years of services and many significant contributions to Padagis.
The Board congratulates Pam on her position and looks forward to working with her to build Padagis’ market leadership position in the pharmaceutical industry and drive future growth. The executive leadership team will now be co-located in the U.S., our primary market, with new corporate offices opening near Grand Rapids in Spring 2023.
Padagis is dedicated to improving the well-being of patients and consumers by providing high quality, affordable specialized healthcare products. The company is a leading provider of extended topical and other specialty pharmaceuticals to its primary markets of the United States and Israel. Padagis employs over 1,300 people worldwide. Visit Padagis online at (http://www.padagis.com).